Loading
Lifecore Biomedical, Inc. \DE\ Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Josephs Paul, was filed 08 Jan 2025.
Lifecore Biomedical, Inc. \DE\: what insiders have been doing
This page follows insider dealings at Lifecore Biomedical, Inc. \DE\ as filed with SEC (Form 4), a company from the Health Care sector. From 22 October 2025 to 22 October 2026, the disclosure feed for Lifecore Biomedical, Inc. \DE\ logged 4 filings by 3 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
No insider has bought Lifecore Biomedical, Inc. \DE\ shares on the open market in the past twelve months. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4.
For context, the typical company on the same exchange (median of 3,171 companies) published 24 filings over the same period, against 4 filings here. Our records for Lifecore Biomedical, Inc. \DE\ go back to 2016, with 63 purchases and 32 sales on the open market in total. On the fundamentals side, the SEC filing (10-K) for the period ending 25 May 2025 lists revenue at 128.9 m USD and net income at -38.7 m USD.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
357
Thresholds
n/a
Buy Volume
€22M
63 ops. · all time
Sell Volume
€11M
32 ops. · all time
Who traded when
BuySaleAron R. English10 sales
Paul Josephs1 buy
Since the insiders bought
- +20.2%Entry US$6.29 · Close at T+365 US$7.56
- +42.8%Entry US$4.81 · Close at T+365 US$6.87
- +42.8%Entry US$4.81 · Close at T+365 US$6.87
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Lifecore Biomedical, Inc. \DE\ Hold (neutral), based on 2 analysts. Average price target: US$6.27.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 23,491 of 26,280 companies
22.5
score / 100
Value18
Quality27
FCF yld-5.5%
Earn yld-16%
EV/EBITDA·
ROE·
Gross mgn31%
Net mgn-30%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended May 2025 · cache
US$6.52
Analyst consensus
2 analystsHold
US$6.25Target US$6.27(-4%)US$6.28
Income statement
RevenueUS$128.9M
Gross profitUS$40.3M31% margin
EBITDA-US$8.5M-7% margin
Net income-US$38.7M-23.8% margin
Valuation
PER (forward)-8.4x
Beta1.09
Balance sheet & cash
Market capUS$247.1M
Total debtUS$142.6M
Free Cash Flow-US$13.6M
Debt / Equity972%
Profitability & ownership
% insiders2.8%
% institutions77.3%
Last declaration on 5 June 2026
Declarations357 total
25,907 sharesCommon StockSEC:0001376960-26-000002:0
25,907 sharesCommon StockSEC:0001800145-26-000002:0
24,645 shares@ US$5.200.066% mcap100.0% of flowCommon StockSEC:0002062209-26-000004:0
30,000 sharesCommon StockSEC:0002062209-26-000002:0
22,932 shares@ US$7.71100.0% of flowCommon StockSEC:0001005286-25-000120:0
19,506 sharesCommon StockSEC:0001005286-25-000094:0
19,506 sharesCommon StockSEC:0001005286-25-000089:0
19,506 sharesCommon StockSEC:0001005286-25-000088:0
19,506 sharesCommon StockSEC:0001005286-25-000092:0
19,506 sharesCommon StockSEC:0001005286-25-000091:0
19,506 sharesCommon StockSEC:0001005286-25-000090:0
19,506 sharesCommon StockSEC:0001005286-25-000087:0
19,506 sharesCommon StockSEC:0000921895-25-002006:0
11,022 shares@ US$8.1941.5% of flowCommon StockSEC:0001005286-25-000080:1
32,806 shares@ US$8.1939.7% of flowCommon StockSEC:0001005286-25-000079:1
54,857 shares@ US$8.1956.1% of flowCommon StockSEC:0001005286-25-000078:1
37,000 sharesCommon StockSEC:0001005286-25-000080:0
75,000 sharesCommon StockSEC:0001005286-25-000079:0
150,000 sharesCommon StockSEC:0001005286-25-000078:0
96,137 shares@ US$6.75486.9% of flowCommon StockSEC:0000950170-25-078524:0
1,139,504 shares@ US$6.504278.5% of flowCommon StockSEC:0000950170-25-078524:1
150,419 shares@ US$7.123811.5% of flowCommon StockSEC:0000950170-25-078524:2
21,532 shares@ US$6.6357.3% of flowCommon StockSEC:0001005286-25-000074:0
12,334 shares@ US$7.00120.9% of flowCommon StockSEC:0000950170-25-073196:0
700 shares@ US$7.000.1% of flowCommon StockSEC:0000950170-25-069576:1
25 of 357 declarations
About Lifecore Biomedical, Inc. \DE\
LIFECORE BIOMEDICAL, INC. is a company focused on the development and manufacturing of biomedical products. It is listed on NASDAQ under the symbol XNAS.
